XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 $ 15,182 $ 369 $ 146,556,418 $ (136,281,630) $ 10,290,339
Balance, shares at Dec. 31, 2022 1,518,158 3,677,775      
Return and cancellation of shares in lieu of payroll tax withholding $ (1) (39,307) (39,308)
Surrender and cancellation of common stock, shares   (10,058)      
Stock-based compensation:          
Restricted share units $ 10 1,188,057 1,188,067
Restricted share units, shares   99,898      
Options 2,190,428 2,190,428
Net loss (as restated) (7,172,572) (7,172,572)
Balance at Mar. 31, 2023 $ 15,182 $ 378 149,895,596 (143,454,202) 6,456,954
Balance, shares at Mar. 31, 2023 1,518,158 3,767,615      
Balance at Dec. 31, 2023 $ 13,982 $ 471 156,689,256 (146,699,334) 10,004,375
Balance, shares at Dec. 31, 2023 1,398,158 4,706,917      
Common stock issued in connection with warrant exchange [1] $ 200 4,742,043 4,742,243
Common stock issued in connection with warrant exercise and extinguishment, shares   2,000,000      
Return and cancellation of shares in lieu of payroll tax withholding $ (4) (48,406) (48,410)
Surrender and cancellation of common stock, shares   (34,825)      
Stock-based compensation:          
Restricted share units $ 10 985,028 985,038
Restricted share units, shares   97,827      
Options 1,043,336 1,043,336
Net loss (as restated) (2,223,255) (2,223,255)
Balance at Mar. 31, 2024 $ 13,982 $ 677 $ 163,411,257 $ (148,922,589) $ 14,503,327
Balance, shares at Mar. 31, 2024 1,398,158 6,769,919      
[1] Represents the aggregate fair value of 3,351,580 shares of common stock, which includes 2,000,000 that have been issued and 1,351,580 shares held in abeyance. See Note 4 - Stockholders’ Equity - Warrant Exercise and Issuance and Note 6 - Fair Value Measurement for additional details.